Medical Benefits of the Biological Defense Research Program

Author:

Dasey Charles F.

Abstract

The U.S. Army conducts the Biological Defense Research Program to provide medical protection for U.S. military personnel against the threat of biological weapons. The unclassified medical research program is consistent with the Biological Weapons Convention, which prohibits the production and stockpiling of biological and toxin weapons, and encourages the international exchange of scientific and medical information on the prevention and treatment of infectious diseases. The program is the source of secondary benefits to civilian public health in the form of vaccine and drug development, diagnostic capability, and contributions to the world body of knowledge on infectious diseases. As the executive agent for the program, the Army submits descriptions of the work conducted under the program to Congress as part of its budget request, and provides numerous other responses to Congressional scrutiny of the program. Internal monitoring of the program is conducted from the perspectives of safety, compliance with regulatory agencies, quality assurance, and close administrative and technical oversight of contracts.

Publisher

Cambridge University Press (CUP)

Subject

Public Administration,Social Sciences (miscellaneous),Sociology and Political Science

Reference10 articles.

1. Article X of the Convention is interpreted as authorizing the type of research conducted under the BDRP: The States Parties to this Convention undertake to facilitate, and have the right to participate in, the fullest possible exchange of equipment, materials and scientific and technological information for the use of bacteriological (biological) agents and toxins for peaceful purposes. Parties to the Convention in a position to do so shall also cooperate in contributing individually or together with other States or international organizations to the further development and application of scientific discoveries in the field of bacteriology (biology) for prevention of disease, or for other peaceful purposes. (2) This Convention shall be implemented in a manner designed to avoid hampering the economic or technological development of States Parties to the Convention or international cooperation in the field of peaceful bacteriological (biological) activities, including the international exchange of bacteriological (biological) agents and toxins and equipment for the processing, use or production of bacteriological (biological) agents and toxins for peaceful purposes in accordance with the provisions of the Convention.

2. Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on their Destruction. Signed at Washington, London and Moscow, April 10,1972. Article I states: Each State Party to this Convention undertakes never in any circumstance to develop, produce, stockpile, or otherwise acquire or retain: (1) Microbial or other biological agents, or toxins whatever their origin or method of production, of types and in quantities that have no justification for prophylactic, protective or other peaceful purposes; (2) Weapons, equipment or means of delivery designed to use such agents or toxins for hostile purposes or in armed conflict.

3. The U.S. Army Chemical Research Development and Engineering Center, Aberdeen Proving Ground, Maryland is responsible for the development of physical protection equipment such as masks and protective garments, and for the development of biological agent monitoring systems. The U.S. Army Dugway Proving Ground, Dugway, Utah, has the mission of testing physical protection and detection systems.

4. Research and development under the BDRP conforms to regulations and standards of the following agencies: the U. S. Department of Agriculture, Department of Health and Human Services, Food and Drug Administration, National Institutes of Health, Public Health Service, Centers for Disease Control, Department of Labor, Department of Transportation, Environmental Protection Agency, Department of Commerce, Department of Energy, Nuclear Regulatory Commission, Department of Defense, and the Department of the Army.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3